Mouad Edderkaoui, PhD

Assistant Professor, Biomedical Sciences

Assistant Professor, Medicine

Mouad Edderkaoui, PhD

Phone:

310-248-8024

Mouad Edderkaoui, PhD

Assistant Professor, Biomedical Sciences

Assistant Professor, Medicine

The research goal of Mouad Edderkaoui, PhD, is to understand the mechanism of pancreatic cancer initiation and progression and to develop a treatment strategy for the disease. Edderkaoui focuses on the role of cells present in the tumor microenvironment and how histone deacetylases (HDACs) regulate the interaction between these cells.

  • Associate Editor: Frontiers in Science, Current
  • Hirshberg Foundation Award, 2012
  • Career Development Award, National Institutes of Health, 2011
  • American Pancreatic Association, 2011
  • American Association for Cancer Research, 2008
  • Edderkaoui M, Hong P, Lee JK, Pandol SJ, Gukovskaya AS. Insulin-like growth factor-I receptor mediates the prosurvival effect of fibronectin. J Biol Chem. 2007 Sep 14;282(37):26646-26655.
  • Edderkaoui M, Lugea A, Hui H, Eibl G, Lu QY, Moro A, Lu X, Li G, Go VL, Pandol SJ. Ellagic acid and embelin affect key cellular components of pancreatic adenocarcinoma, cancer, and stellate cells. Nutr Cancer. 2013;65(8):1232-1244.
  • Edderkaoui M, Nitsche C, Zheng L, Pandol SJ, Gukovsky I, Gukovskaya AS. NADPH oxidase activation in pancreatic cancer cells is mediated through Akt-dependent up-regulation of p22phox. J Biol Chem. 2011 Mar 11;286(10):7779-7787.

English

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.